What sector is CPSR in?

Healthcare, in the Pharmaceuticals industry.

NYSE Arca · CPSRHealthcarePharmaceuticals

Calamos S&P 500 Structured Alt Protection ETF - March (CPSR)

$26.31−0.02%

Close Nov 12, 2026 · split-adjusted

Nov 12, 2026$26.31▲ 5.45% in range

Nov 12, 2025Low $24.80 · High $26.32Nov 12, 2026

What changed · written from our data

As of Nov 12, 2026

Calamos S&P 500 Structured Alt Protection ETF - March closed at $26.31 on Nov 12, down 0.02% — matching its 52-week closing high. Volume of 1.7K shares was 2.42× its 20-day average (well above normal).

Split-adjusted performance: +0.2% over one month, +2.1% over six months, +5.5% over one year.

In the quarter ended Jun 30, 2023, revenue was $1.11M, down 87.7% from a year earlier, with a net margin of -693.9%.

Short interest was 2.3K shares at the Oct 30 settlement, up 570.2% from the prior report (5.3 days to cover).

Market cap—

Revenue · quarter$1.1M−87.7% YoY

Diluted EPS$-0.10—

P/E · TTM—

Net margin-693.9%Gross 55.0%

Dividend yieldNone

52-week range24.80 – 26.320.0% from high

Volume1.7K2.42× 20-day avg

Volatility · 60d2.1%Annualised

Short % of float—5.3 days to cover

Net cash-$52.7MCash $7.9M

Next earnings—Not scheduled

Split-adjusted performance

1W +0.6%1M +0.2%3M +0.9%6M +2.1%YTD +4.4%1Y +5.5%3Y —5Y +163.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 419 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −26.6%, revenue growth +10.0%, net margin −36.2%, P/E 17.1×.

Short interest

Details →

Shares short2.3K+570.2% vs prior

Days to cover5.3Settled Oct 30

% of float—

Short vol. 10d34.1%of daily volume

News about Calamos S&P 500 Structured Alt Protection ETF - March

All news →

No recent articles focused on Calamos S&P 500 Structured Alt Protection ETF - March.

Quick answers

What sector is CPSR in?: Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology